4-(6-(4-(2-methoxyethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N-(2,2,2-trifluoroethyl)thiophene-2-carboxamide

ID: ALA4593028

PubChem CID: 70841494

Max Phase: Preclinical

Molecular Formula: C22H19F3N4O3S

Molecular Weight: 476.48

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COCCOc1ccc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cc1

Standard InChI:  InChI=1S/C22H19F3N4O3S/c1-31-6-7-32-17-4-2-14(3-5-17)16-9-26-20-18(10-28-29(20)11-16)15-8-19(33-12-15)21(30)27-13-22(23,24)25/h2-5,8-12H,6-7,13H2,1H3,(H,27,30)

Standard InChI Key:  BBEQRPZTAJPSME-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    6.5251   -9.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5251  -10.4089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2304  -10.8133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2304   -9.1790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9357   -9.5917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9357  -10.4099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7138  -10.6628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1949  -10.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7139   -9.3389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9680  -11.4441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4876  -12.1052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9679  -12.7664    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.7451  -12.5139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7451  -11.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4063  -12.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3208  -13.8070    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1528  -12.6619    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8139  -13.1422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5605  -12.8098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2216  -13.2902    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6459  -11.9971    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.2649  -12.3941    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.8186   -9.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8176   -8.3690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1095   -7.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4020   -8.3732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4071   -9.1947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1157   -9.5974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6926   -7.9677    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9866   -8.3793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2772   -7.9737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5712   -8.3853    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8618   -7.9797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  7 10  1  0
 13 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
  1 23  1  0
 26 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Associated Targets(Human)

MARK3 Tchem Serine/threonine-protein kinase c-TAK1 (2532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.48Molecular Weight (Monoisotopic): 476.1130AlogP: 4.44#Rotatable Bonds: 8
Polar Surface Area: 77.75Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.90CX Basic pKa: 0.98CX LogP: 3.69CX LogD: 3.69
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.38Np Likeness Score: -1.86

References

1. Sloman DL, Noucti N, Altman MD, Chen D, Mislak AC, Szewczak A, Hayashi M, Warren L, Dellovade T, Wu Z, Marcus J, Walker D, Su HP, Edavettal SC, Munshi S, Hutton M, Nuthall H, Stanton MG..  (2016)  Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties.,  26  (17): [PMID:27491711] [10.1016/j.bmcl.2016.02.003]

Source